Skip to content
Search

Latest Stories

New study shows promise of prebiotic fiber in managing Pre-Diabetes

New study shows promise of prebiotic fiber in managing Pre-Diabetes
Researchers find significant improvements in insulin sensitivity and other health markers, offering hope for millions at risk of type 2 diabetes

A recent study published in the British Journal of Nutrition reveals promising results regarding the use of daily prebiotic fiber supplements in patients with pre-diabetes, suggesting significant improvements in insulin sensitivity and other vital health markers.

"Pre-diabetes affects over 7 million individuals in the UK," says Dr. Thomas Gurry, CEO at myota. "Our findings have shown that prebiotic fiber represents a promising and efficacious fast-acting treatment to manage pre-diabetes."


Conducted over 24 weeks with 66 prediabetic participants, the study, led by scientists from myota and CRO Lindus Health, utilised a diverse prebiotic blend.

"The results of our study suggest that this natural diverse prebiotic fiber supplement could be taken to reverse pre-diabetes and to prevent or slow the onset of type 2 diabetes," says Dr. Caitlin Hall, Head of Research at myota.

"These findings are crucial for millions of pre-diabetes patients," emphasises Dr. Luke Twelves, Medical Director at Lindus Health.

"The potential to slow or prevent the progression from pre-diabetes to diabetes would obviously have a significant benefit for the individual patient but would also bring substantial benefits across the wider health service, by reducing the pressure on health services."

Encouragingly, the treatment group showed significant improvements in HbA1c levels, insulin sensitivity, fasting plasma insulin, and C-reactive protein compared to the placebo group, all without significant lifestyle or dietary modifications.

"The significant variation in the composition of each person’s gut microbiome has historically limited the production of a clinically effective prebiotic fiber supplement," explains Dr. Thomas Gurry.

"However, following a decade of research into the gut microbiome and fiber fermentation, the myota scientific team developed a natural prebiotic supplement that optimises SCFA production across every microbiome."

"The NHS is now investigating the impact of prebiotic fiber supplements on pre-diabetes and type 2 diabetes, signaling a potential shift in treatment paradigms," concludes Dr. Luke Twelves.

"Clinicians currently have limited options to treat pre-diabetes, and treatment is focused on lifestyle interventions which have variable impact.

"This research is therefore exciting in that it points to a simple, cost-effective treatment that could work alongside existing interventions and could significantly change the course of the disease," he continued.

More For You

Hay fever treatment: Dymista nasal spray now available in pharmacies without prescription

Hay fever affects one in four people in the UK

gettyimages

Hay fever treatment: First OTC combination nasal spray launched

For the first time, a double-action combination treatment for moderate to severe hay fever has been available over the counter across UK pharmacies, offering a new option for those sufferers who remain uncontrolled on a corticosteroid or antihistamine nasal spray.

Launched by global healthcare company Viatris, Dymista® CONTROL (azelastine hydrochloride and fluticasone propionate) nasal spray— previously only available via prescription under the brand name Dymista — can be accessed without a GP visit.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less